Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer-Reference-Cited by-同舟云学术

Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer

Published:2017-10-02 Issue:1 Volume:15 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Ballestrero Alberto,Bedognetti Davide,Ferraioli Domenico,Franceschelli Paola,Labidi-Galy Sana Intidhar,Leo Elisabetta,Murai Junko,Pommier Yves,Tsantoulis Petros,Vellone Valerio Gaetano,Zoppoli Gabriele

Funder

Università degli Studi di Genova (IT)

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-017-1296-3.pdf

Reference35 articles.

1. Schwarz DA, Katayama CD, Hedrick SM. Schlafen, a new family of growth regulatory genes that affect thymocyte development. Immunity. 1998;9:657–68.

2. Liu F, Zhou P, Wang Q, Zhang M, Li D. The Schlafen family: complex roles in different cell types and virus replication. Cell Biol Int. 2017. doi: 10.1002/cbin.10778 .

3. Zoppoli G, Regairaz M, Leo E, Reinhold WC, Varma S, Ballestrero A, et al. Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents. Proc Natl Acad Sci USA. 2012;109:15030–5.

4. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483:603–7.

5. Li M, Kao E, Gao X, Sandig H, Limmer K, Pavon-Eternod M, et al. Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. Nature. 2012;491:125–8.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemical Evaluation of Schlafen 11 (SLFN11) Expression in Cancer in the Search of Biomarker-Informed Treatment Targets;American Journal of Surgical Pathology;2024-08-26

2. Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients;Molecular Oncology;2024-07-02

3. The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancer;Cancer Treatment Reviews;2024-07

4. Therapeutic Targeting of DNA Repair Pathways in Pediatric Extracranial Solid Tumors: Current State and Implications for Immunotherapy;Cancers;2024-04-25

5. Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration;European Journal of Cancer;2023-09